News

As the Swedish pharmaceutical pipeline continues to mature, attention is increasingly turning to the factors that support successful development, market access, and commercialization of innovative…

Participation in hospital procurement and tendering is not just an operational requirement, but a key aspect of pharmaceutical companies’ market access strategy. By engaging in…

Real-world evidence (RWE) has become increasingly visible in health technology assessment (HTA) discussions across Europe. In the Nordic countries, however, its role remains distinctive —…